Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Short on Competition Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to authorize importation of life-saving drugs for which there is, or is likely to be, a shortage. For a drug to be imported, the drug's manufacturer must intend to seek FDA approval of the drug as a generic drug. The FDA may deny importation of a drug for reasons related to safety or effectiveness. Drugs in noncompetitive markets must be treated as being in a shortage for purposes of this bill and for purposes of expedited inspections and review. A drug is in a noncompetitive market if: (1) there are fewer than five holders of approved applications for commercially available brand name or generic versions of the drug, (2) the drug has been approved for at least 10 years, and (3) patents on the active ingredient of the drug have expired.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues pertaining to tax treatment of employee-sponsored health benefits; Pub. L. 111-148, the Patient Protection and Affordable Care Act; Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010, provision related to insurer fee; H.R. 928 & S. 183, a bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; H.R. 1628, American Health Care Act, Section 222; H.R.3315 Protecting Consumer Access to Vision Care Act of 2017
Client expense: $132,500 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · fourth_quarter · Taxation/Internal Revenue Code
Health Insurance Tax; IRC section 833(b) tax provisions; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Tax ID number reporting; Cadillac tax; Tax extenders; Device tax repeal; Tax reform HR 928 Introduced February 12, 2015 by Charles Boustany (RLA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. S 183 Introduced January 16, 2015 by John Barrasso (RWY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
2017 · third_quarter · Taxation/Internal Revenue Code
Health Insurance Tax; IRC section 833(b) tax provisions; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Tax ID number reporting; Cadillac tax; Tax extenders; Device tax repeal; Tax reform HR 928 Introduced February 12, 2015 by Charles Boustany (RLA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. S 183 Introduced January 16, 2015 by John Barrasso (RWY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
2017 · third_quarter · Taxation/Internal Revenue Code
833; Health Insurance Tax (HIT Tax); Cadillac Tax HR 173 Middle Class Health Venefit Tax Repeal Act Introduced January 3, 2017 by Mike Kelly (R-PA) to amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. S. 183 - 115th Congress (2017-2018) Short on Competition Act Sponsor: Sen. Klobuchar, Amy (D-MN) (Introduced 1/20/2017)
Client expense: $79,860 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Taxation/Internal Revenue Code
833; Health Insurance Tax (HIT Tax); Cadillac Tax; Tax Credits HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage; S.183 - 115th Congress (2017-2018) Short on Competition Act Sponsor: Sen. Klobuchar, Amy [D-MN] (Introduced 01/20/2017)
Client expense: $2,040,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
Issues pertaining to tax treatment of employee-sponsored health benefits; Pub. L. 111-148, the Patient Protection and Affordable Care Act; Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010, provision related to insurer fee; H.R. 928 & S. 183, a bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; H.R. 1628, American Health Care Act, Section 222; H.R.3315 Protecting Consumer Access to Vision Care Act of 2017
Client expense: $102,500 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · second_quarter · Health Issues
Issues related to Affordable Care Act repeal and replace; health issues related Zika vaccine development; issues related to H.R. 749 Lower Cost Through Drug Competition Act, ; issues related to drug importation; issues related to H.R. 1245 Affordable and Safe Prescription Drug Importation Act; issues related to S. 64 Safe and Affordable Drugs from Canada Act of 2017; issues related to Over the Counter (OTC) Monograph reform; general issues related to drug pricing; issues related to S.183 Short on Competition Act; issues related to S.934 FDA Reauthorization Act of 2017; issues related to H.R. 2212 CREATES Act of 2017; issues related to H.R. 1231 RACE for Children Act; drug price transparency issues related to H.R. 2439 Fair Accountability and Innovative Research Drug Pricing Act of 2017; drug price transparency related to S. 1131 Fair Accountability and Innovative Research Drug Pricing Act of 2017; issues related to H.R. 1703Medical Product Communications Act of 2017; issues related to H.R. 1148 FAST Act of 2017; issues related to S. 456 RACE for Children Act; issues related to H.R. 2368 Right to Try Act; issues related to H.R. 1223 OPEN Act; issues related to H.R. 2430 FDA Reauthorization Act of 201; issues related to S. 204 Right to Try Act; issues related to H.R. 1480 Safe and Affordable Drugs from Canada Act of 2017; issues related to H.R. 3165 REVAMP Act of 2017 (draft); issues related to H.J. Res. 51 Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act; general issues related to the Food and Drug Administration User Fee Reauthorization
Client expense: $740,000 · Firm income: Not reported
2017 · second_quarter · Taxation/Internal Revenue Code
Health Insurance Tax; IRC section 833(b) tax provisions; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Tax ID number reporting; Cadillac tax; Tax extenders; Device tax repeal; Tax reform HR 928 Introduced February 12, 2015 by Charles Boustany (RLA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. S 183 Introduced January 16, 2015 by John Barrasso (RWY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Client expense: Not reported · Firm income: $50,000
Issues pertaining to tax treatment of employee-sponsored health benefits; Pub. L. 111-148, the Patient Protection and Affordable Care Act; Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010, provision related to insurer fee; H.R. 928 & S. 183, a bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; H.R. 1628, American Health Care Act, Section 222
Client expense: $97,250 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · first_quarter · Taxation/Internal Revenue Code
Health Insurance Tax; IRC section 833(b) tax provisions; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Tax ID number reporting; Cadillac tax; Tax extenders; Device tax repeal; Tax reform HR 928 Introduced February 12, 2015 by Charles Boustany (RLA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. S 183 Introduced January 16, 2015 by John Barrasso (RWY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Client expense: Not reported · Firm income: $50,000
2017 · first_quarter · Taxation/Internal Revenue Code
Issues pertaining to tax treatment of employee-sponsored health benefits; Pub. L. 111-148, the Patient Protection and Affordable Care Act; Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010, provision related to insurer fee; H.R. 928 & S. 183, a bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; H.R. 1628, American Health Care Act, Section 222.
Client expense: Not reported · Firm income: $50,000
Issues pertaining to tax treatment of employee-sponsored health benefits; Pub. L. 111-148, the Patient Protection and Affordable Care Act; Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010, provision related to insurer fee; H.R. 928 & S. 183, a bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; H.R. 1628, American Health Care Act, Section 222
Client expense: $97,250 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · first_quarter · Pharmacy
Advise on standards setting verification, overseas programs, and quality medicines - activities related to drugs, dietary supplements, food ingredients, and compounding HR 934, Personal Drug Importation Fairness Act of 2017; provisions related to importation. HR 1020, Compassionate Freedom of Choice Act of 2017; provisions related to importation. S 92/S 64, Safe and Affordable Drugs from Canada Act of 2017; provisions related to importation. S 183, Short on Competition Act; provisions related to importation. S. 469, the Affordable and Safe Prescription Drug Importation Act; provisions related to importation. Medication adherence HR 592/S 109, Pharmacy and Medically Underserved Areas Enhancement Act; provisions related to provider status. User fee agreements HR 749, Lower Drug Costs Through Competition Act; provisions related to generic competition
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE